Deep Anterior Lamellar Keratoplasty (DALK) Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients
1 other identifier
interventional
78
1 country
1
Brief Summary
The purpose of this study is to study whether deep anterior lamellar keratoplasty (DALK) using acellular tissue will promote corneal graft survival in high risk patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2006
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 25, 2009
CompletedFirst Posted
Study publicly available on registry
November 26, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedAugust 3, 2010
November 1, 2006
3.6 years
November 25, 2009
August 2, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
rejection
Secondary Outcomes (1)
laser scanning in vivo confocal microscopy
Study Arms (2)
GCCT,corneal allograft survival ,DALK
EXPERIMENTALexperimental group: deep anterior lamellar keratoplasty using glycerin-cryopreserved corneal tissue
FCT,corneal allograft survival ,DALK
EXPERIMENTALcontrol group: deep anterior lamellar keratoplasty using fresh corneal tissue
Interventions
Deep anterior lamellar keratoplasty (DALK) using glycerin-cryopreserved corneal tissue
Deep anterior lamellar keratoplasty (DALK) using fresh corneal tissue
Eligibility Criteria
You may qualify if:
- severe bacterial keratitis
- Herpes simplex keratitis
- severe fungal keratitis
- partial limbal deficiency after chemical burn
You may not qualify if:
- posterior stroma involved in severe bacterial and fungal keratitis
- dry eye
- glaucoma or intraocular pressure greater than 21 mmHg
- amblyopia
- retinal abnormalities
- patients with severe systemic diseases not good for ocular surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eye Hospital, Wenzhou Medical College
Wenzhou, Zhejiang, 325027, China
Related Publications (1)
Li J, Yu L, Deng Z, Wang L, Sun L, Ma H, Chen W. Deep anterior lamellar keratoplasty using acellular corneal tissue for prevention of allograft rejection in high-risk corneas. Am J Ophthalmol. 2011 Nov;152(5):762-70.e3. doi: 10.1016/j.ajo.2011.05.002. Epub 2011 Jul 30.
PMID: 21803324DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wei Chen, MD,PhD
Eye Hospital, Wenzhou Medical College, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 25, 2009
First Posted
November 26, 2009
Study Start
December 1, 2006
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
August 3, 2010
Record last verified: 2006-11